Tizon, Candido T.
HRN: 14-84-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
LEVOFLOXACIN 500MG (TAB)
07/12/2024
07/18/2024
PO
500mg
OD 7days
S/P UTZ GUIDED TRANSPERINEAL BIOPSY OF THE PROSTATE GL AND
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes